116 related articles for article (PubMed ID: 7220656)
1. Interactions of zinc and arachidonic acid.
Peterson DA; Gerrard JM; Peller J; Rao GH; White JG
Prostaglandins Med; 1981 Jan; 6(1):91-9. PubMed ID: 7220656
[TBL] [Abstract][Full Text] [Related]
2. The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid.
Rao GH; Gerrard JM; Eaton JW; White JG
Prostaglandins Med; 1978 Jul; 1(1):55-70. PubMed ID: 715048
[TBL] [Abstract][Full Text] [Related]
3. Beclobrinic acid--a new hypolipidemic agent--inhibits in vitro human platelet activation by blocking prostaglandin synthesis.
Anwer K; Gabis J; Romstedt K; Gojer C; Huzoor-Akbar
Life Sci; 1985 Jul; 37(1):63-70. PubMed ID: 3925267
[TBL] [Abstract][Full Text] [Related]
4. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
5. Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.
Burns GB; Dodge JA
Agents Actions; 1984 Jan; 14(1):102-8. PubMed ID: 6322546
[TBL] [Abstract][Full Text] [Related]
6. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
7. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
8. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
Vericel E; Lagarde M
Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
[TBL] [Abstract][Full Text] [Related]
9. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
Rao GH; Radha E; White JG
Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
[TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacology of cyclooxygenase inhibitors on platelet function.
Rao GH; White JG
Prostaglandins Leukot Med; 1985 Apr; 18(1):119-31. PubMed ID: 3159025
[TBL] [Abstract][Full Text] [Related]
11. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
12. Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function.
Rao GH; Cox AC; Gerrard JM; White JG
Biochim Biophys Acta; 1980 Apr; 628(4):468-79. PubMed ID: 7370301
[TBL] [Abstract][Full Text] [Related]
13. 1-arachidonyl-monoglyceride causes platelet aggregation: indirect evidence for an acylglycerol acylhydrolase involvement in the release of arachidonic acid for prostaglandin synthesis.
Gerrard JM; Graff G
Prostaglandins Med; 1980 Jun; 4(6):419-30. PubMed ID: 7413843
[TBL] [Abstract][Full Text] [Related]
14. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
15. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
16. Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man.
Rosenkranz B; Fischer C; Meese CO; Frölich JC
Br J Clin Pharmacol; 1986 Mar; 21(3):309-17. PubMed ID: 3083851
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
Samuelsson B
Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of thrombocyte aggregation and thromboxane B2 synthesis by diethylstilbestrol.
Subbiah MT; Gallon L; Yunker R
Pharmacology; 1980; 21(6):396-9. PubMed ID: 7220591
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of platelet aggregation and thromboxane production by pinacidil.
Goodman RP; Little DM; Wright JT
Prostaglandins Leukot Med; 1985 Aug; 19(2):115-22. PubMed ID: 3931098
[TBL] [Abstract][Full Text] [Related]
20. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
